A case of dystrophic epidermolysis bullosa with a rare COL7A1 variant
Patrícia Amoedo +3 more
openaire +3 more sources
How far have we come? From understanding collagen disorders to advancing treatment strategies. [PDF]
Williamson J +3 more
europepmc +1 more source
Narrowing the Differential: A Unique Case of Dystrophic Epidermolysis Bullosa. [PDF]
Yacobucci L +3 more
europepmc +1 more source
Innovations in topical epidermolysis bullosa treatment: integrating advanced dressings, bioactive therapies and tissue-engineered skin. [PDF]
Marwah MK, Kaur K, Ahmad S, Cheema HCK.
europepmc +1 more source
Integrated clinicopathological, genomic, and immunophenotypic landscape of renal tubulocystic oncocytoma. [PDF]
Wang W +9 more
europepmc +1 more source
Clinical and Allelic Heterogeneity in a Small Cohort of Patients with Inherited Epidermolysis Bullosa. [PDF]
Buianova AA +13 more
europepmc +1 more source
Human urine-derived stem cells rescue cutaneous manifestation and suppress inflammation and fibrosis <i>in vitro</i> and in a mouse model of recessive dystrophic epidermolysis bullosa. [PDF]
Zhou X +15 more
europepmc +1 more source
Gene editing for collagen disorders: current advances and future perspectives. [PDF]
Kocsy K +6 more
europepmc +1 more source
A Novel Selective Strategy for Bioactive Limbal Stem Cells Primary Culture Using Deep Cryopreservation and IL-1β Precondition. [PDF]
Liu Y +7 more
europepmc +1 more source
Dystrophic epidermolysis bullosa caused by novel frameshift mutation in the <i>COL7A1</i> gene: A case report. [PDF]
Yang Y, Guan ZW, Li QF.
europepmc +1 more source

